- Latest available (Revised)
- Original (As made)
The Medical Devices (Northern Ireland Protocol) Regulations 2021
You are here:
- UK Statutory Instruments
- 2021 No. 905
- PART 4
- Regulation 19
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Changes over time for: Section 19
Alternative versions:
Changes to legislation:
There are currently no known outstanding effects for the The Medical Devices (Northern Ireland Protocol) Regulations 2021, Section 19.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Fees payable in connection with the designation of notified bodiesU.K.
This section has no associated Explanatory Memorandum
19.—(1) Fees in connection with the designation of notified bodies are set out in Schedule 2.
(2) The applicant must pay the Secretary of State the fee specified in table 1 in Schedule 2 for an application—
(a)for initial designation as a notified body under Article 38 [F1of Regulation (EU) 2017/745 or Article 34 of Regulation (EU) 2017/746];
(b)for reassessment under Article 44(10) [F2of Regulation (EU) 2017/745 or Article 40(10) of Regulation (EU) 2017/746];
(c)to extend the scope of a designation under Article 46(1) [F3of Regulation (EU) 2017/745 or Article 42(1) of Regulation (EU) 2017/746].
(3) A notified body designated by the Secretary of State under Article 42 [F4of Regulation (EU) 2017/745] that submits a summary evaluation report to the Secretary of State in accordance with Article 5(4) of Regulation (EU) 722/2012, must pay to the Secretary of State a fee of [F5£1,297].
(4) A fee specified in table 1 in Schedule 2 or paragraph (3) is payable when the application or submission to which it relates is made to the Secretary of State.
(5) If an applicant fails to pay a fee specified in table 1 in Schedule 2 or paragraph (3), the Secretary of State may reject the application or submission to which it relates.
(6) If the Secretary of State conducts an assessment or review listed in table 2 in Schedule 2, the fee payable by the conformity assessment body is—
(a)the fee specified for that assessment or review in table 2 in Schedule 2,
(b)an amount for time spent by each member of staff to undertake the assessment or review at a rate—
(i)for the time spent on site, of [F6£631] per half day (period of less than a half day counting as a half day) up to a maximum of 2 half days on any one date, and
(ii)for the time spent travelling to and from the site, of [F7£171] per hour,
(c)the actual costs of travel, accommodation and subsistence, and
(d)out of pocket expenses.
(7) A fee under paragraph (6) is payable within one month of receipt by the conformity assessment body of a written notice from the Secretary of State requiring payment of the fee.
(8) If a conformity assessment body fails to pay a fee under paragraph (6), the Secretary of State may—
(a)refuse to designate the body under Article 42 [F8of Regulation (EU) 2017/745 or Article 38 of Regulation (EU) 2017/746];
(b)if the body has already been designated, suspend, restrict, or fully or partially withdraw, the designation.
(9) In this regulation, “Regulation (EU) 722/2012” means Commission Regulation (EU) No 722/2012 of 8th August 2012 concerning particular requirements as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin(1).
Textual Amendments
F1Words in reg. 19(2)(a) inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 39(a)(i)
F2Words in reg. 19(2)(b) inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 39(a)(ii)
F3Words in reg. 19(2)(c) inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 39(a)(iii)
F4Words in reg. 19(3) inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 39(b)
F5Sum in reg. 19(3) substituted (1.4.2023) by The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023 (S.I. 2023/377), regs. 1(2), 22(2)
F6Sum in reg. 19(6)(b)(i) substituted (1.4.2023) by The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023 (S.I. 2023/377), regs. 1(2), 22(3)(a)
F7Sum in reg. 19(6)(b)(ii) substituted (1.4.2023) by The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023 (S.I. 2023/377), regs. 1(2), 22(3)(b)
F8Words in reg. 19(8)(a) inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 39(c)
Commencement Information
I1Reg. 19 in force at 27.7.2021, see reg. 1(2)
(1)
OJ No. L 212, 09.08.2012, p. 3.
Options/Help
Print Options
PrintThe Whole Instrument
PrintThe Whole Part
PrintThis Section only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.